Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.96% | -42.72% | 12.70% | -0.76% | -6.53% |
| Total Depreciation and Amortization | -0.42% | 1.72% | -1.28% | -10.98% | 23.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.53% | 1.31% | -8.82% | 1.21% | 16.07% |
| Change in Net Operating Assets | -162.13% | 204.95% | -478.43% | 197.64% | -132.94% |
| Cash from Operations | -97.14% | 29.21% | -45.19% | 19.74% | -82.60% |
| Capital Expenditure | 42.31% | -- | -- | -7.69% | 70.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.50% | -200.99% | -350.27% | 98.64% | -- |
| Cash from Investing | 51.46% | -202.41% | -352.70% | 100.00% | 1,743.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.38% | 5.26% | 0.00% | -5.84% | -31.82% |
| Issuance of Common Stock | -38.76% | 93.42% | 135.73% | -13.51% | 234.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.94% | 1.72% | -3.28% | 7.81% | -36.43% |
| Cash from Financing | -42.30% | 103.48% | 166.32% | -15.04% | 395.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -215.96% | 536.70% | -170.38% | 436.25% | 86.78% |
